NSE · ZYDUSLIFE
Zydus Lifesciences Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#82
of 5,072 stocks
▲ 61W
Peak #82 · 27 Sep 2026
Zydus Lifesciences Limited is a megacap company in the Healthcare space and remains firmly promoter-controlled, with promoters holding 75%, is growing revenue at a solid clip, and trades at a moderate earnings multiple.
Market Cap
120,149.22 Cr
P/E Ratio
24.03
P/B Ratio
4.09
ROE
17.32%
ROCE
20.65%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 8,017.00 Cr | 7,587.00 Cr | 6,864.50 Cr | 6,123.20 Cr |
| Net Profit | 990.20 Cr | 1,341.00 Cr | 1,022.90 Cr | 1,238.60 Cr |
| EPS | 9.35 | 12.65 | 10.36 | 12.51 |
| Operating Profit | 1,480.80 Cr | 2,180.20 Cr | 1,568.20 Cr | 1,822.90 Cr |
Shareholding pattern
Promoter
75.01%
Public
24.99%
PUBLIC BREAKDOWN
FII
6.88%
DII
11.27%
MF (within DII)
5.12%
Individuals
5.79%
Mutual fund holdings
₹6,863.41
Cr total
181
Schemes
34
Fund Houses
₹6,863.41 Cr
Total Exposure
Parag Parikh Mutual Fund₹2,333.43 Cr (34.0%)
Kotak Mahindra Mutual Fund₹1,356.89 Cr (19.8%)
Quant Mutual Fund₹890.14 Cr (13.0%)
ICICI Prudential Mutual Fund₹525.75 Cr (7.7%)
HSBC Mutual Fund₹343.12 Cr (5.0%)
Others₹1,414.07 Cr (20.6%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 24 Jul 2026 | Dividend | Dividend - Re 1 Per Share |
| 29 May 2026 | Buyback | Buy Back |
| 25 Jul 2025 | Dividend | Dividend - Rs 11 Per Share |
| 26 Jul 2024 | Dividend | Dividend - Rs 3 Per Share |
| 23 Feb 2024 | Buyback | Buy Back |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.